Correlation Between Gilead Sciences and AbbVie
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and AbbVie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and AbbVie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and AbbVie Inc, you can compare the effects of market volatilities on Gilead Sciences and AbbVie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of AbbVie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and AbbVie.
Diversification Opportunities for Gilead Sciences and AbbVie
0.95 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Gilead and AbbVie is 0.95. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and AbbVie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AbbVie Inc and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with AbbVie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AbbVie Inc has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and AbbVie go up and down completely randomly.
Pair Corralation between Gilead Sciences and AbbVie
Given the investment horizon of 90 days Gilead Sciences is expected to generate 1.13 times more return on investment than AbbVie. However, Gilead Sciences is 1.13 times more volatile than AbbVie Inc. It trades about 0.22 of its potential returns per unit of risk. AbbVie Inc is currently generating about 0.2 per unit of risk. If you would invest 9,137 in Gilead Sciences on December 29, 2024 and sell it today you would earn a total of 2,042 from holding Gilead Sciences or generate 22.35% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Gilead Sciences vs. AbbVie Inc
Performance |
Timeline |
Gilead Sciences |
AbbVie Inc |
Gilead Sciences and AbbVie Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Gilead Sciences and AbbVie
The main advantage of trading using opposite Gilead Sciences and AbbVie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, AbbVie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will offset losses from the drop in AbbVie's long position.Gilead Sciences vs. Amgen Inc | Gilead Sciences vs. Merck Company | Gilead Sciences vs. AbbVie Inc | Gilead Sciences vs. Johnson Johnson |
AbbVie vs. Merck Company | AbbVie vs. Pfizer Inc | AbbVie vs. Eli Lilly and | AbbVie vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |